Structure

InChI Key ORFOPKXBNMVMKC-DWVKKRMSSA-N
Smile CC(C)(O/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccccc3)CS[C@H]12)c1csc(N)n1)C(=O)O
InChI
InChI=1S/C22H22N6O7S2/c1-22(2,20(33)34)35-26-13(12-10-37-21(23)24-12)16(29)25-14-17(30)28-15(19(31)32)11(9-36-18(14)28)8-27-6-4-3-5-7-27/h3-7,10,14,18H,8-9H2,1-2H3,(H4-,23,24,25,29,31,32,33,34)/b26-13-/t14-,18-/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C22H22N6O7S2
Molecular Weight 546.59
AlogP -1.3
Hydrogen Bond Acceptor 11.0
Hydrogen Bond Donor 3.0
Number of Rotational Bond 9.0
Polar Surface Area 191.22
Molecular species ACID
Aromatic Rings 2.0
Heavy Atoms 37.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Bacterial penicillin-binding protein inhibitor
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Hydrolase
- - - - 1.037
Enzyme Protease
- 0.1 - - -
Enzyme Transferase
- 4 - - 12.78
Epigenetic regulator Eraser Histone deacetylase HDAC class IIb
- - - - -24.44--7.81
Unclassified protein
- - - - 100

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Urinary Tract Infections 4 D014552 ClinicalTrials
Pyelonephritis 4 D011704 ClinicalTrials
Peritonitis 4 D010538 ClinicalTrials
Skin Diseases 3 D012871 ClinicalTrials
Staphylococcal Skin Infections 3 D013207 ClinicalTrials
Enterobacteriaceae Infections 3 D004756 ClinicalTrials
Esophageal Achalasia 2 D004931 ClinicalTrials
Meningitis, Bacterial 2 D016920 ClinicalTrials
Osteomyelitis 1 D010019 ClinicalTrials
Cystic Fibrosis 1 D003550 ClinicalTrials

Related Entries

MCS

Scaffolds

Salt
Mixture

Side Effects from Label

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
12.18
Skin and subcutaneous tissue disorders
9.21
Infections and infestations
8.05
Vascular disorders
8.05
Nervous system disorders
7.68
Injury, poisoning and procedural complications
7.2
Blood and lymphatic system disorders
6.03
Gastrointestinal disorders
5.56
Immune system disorders
5.13
Cardiac disorders
4.64
Respiratory, thoracic and mediastinal disorders
4.48
Hepatobiliary disorders
3.67
Metabolism and nutrition disorders
3.11
Psychiatric disorders
3.11
Product issues
2.82
Renal and urinary disorders
2.75
Investigations
2.26

Cross References

Resources Reference
CAS NUMBER 72558-82-8
ChEBI 3508
ChEMBL CHEMBL44354
DrugBank DB00438
EPA CompTox DTXSID5022770
FDA SRS 9M416Z9QNR
Human Metabolome Database HMDB14582
Guide to Pharmacology 10762
KEGG C06889
PharmGKB PA448861
PubChem 5481173
SureChEMBL SCHEMBL36849
ZINC ZINC03871960